CMPS stock news · Compass Pathways

Stories about Compass Pathways (CMPS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CMPS

Follow Compass Pathways (CMPS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 2, 2026, 1:05 PM ET · Market
Compass Pathways and the Depression and Bipolar Support Alliance shared a survey showing the struggles of patients with tough-to-treat depression.
Neutral
Compass Pathways published a survey of 261 patients and 73 caregivers; 95% said daily life was a struggle or mere survival. It shows a need for options, not a change in Compass's outlook.
Oct 8, 2026, 3:33 AM ET · Results
Compass Pathways shares its financial results for the second quarter of 2026, including the full earnings call details.
Good for CMPS
Compass Pathways reported successful late-stage trial results and plans to finish its drug application in Q4 2026. This supports its outlook, though approval is not assured.